NEW

FDA clears first fully disposable duodenoscope, eliminating the potential for infections caused by ineffective reprocessing

The U.S. Food and Drug Administration today cleared for marketing in the U.S. the first fully disposable duodenoscope. The EXALT Model D Single-Use Duodenoscope is intended to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct...

Webinar Addresses ‘Hot Topic’

The recent OR Today webinar “Human Factors and Quality Testing for Device Reprocessing” was sponsored by Healthmark and eligible for one (1) continuing education (CE) hour by the State of California Board of Registered Nursing. The 60-minute webinar featured Jahan...

Nihon Kohden Introduces First Subscription-Based Pricing for Patient Monitoring, Neurology Products

Nihon Kohden, a U.S. market leader in precision medical products and services, has launched subscription-based pricing models for its patient monitoring and neurology products, the first in the industry to take such a step. The pricing models help align costs with...

Nihon Kohden Launches Life Scope SVM-7200 Series

Nihon Kohden has announced the launch of its Life Scope SVM-7200 Series vital signs monitor, a monitor designed for outpatient facilities and beds that traditionally are not continuously monitored. The monitor allows health care practitioners to quickly and easily...

ZOLL Announces the Acquisition of Philips InnerCool Temperature Management

ZOLL Medical Corp. has signed an agreement to purchase substantially all of the assets of Philips’ InnerCool temperature management business, which includes catheter-based endovascular and surface temperature management technologies designed to improve outcomes for patients with a variety of temperature management-related needs.

InnerCool’s technology includes the RTx Endovascular System, the Accutrol Catheter, and the CoolRepeat and STx Surface Cooling Systems. All four products have regulatory clearance in the United States. The acquisition provides synergy with ZOLL’s acute critical care portfolio of temperature management products.

“The combination of InnerCool with ZOLL’s existing temperature management technologies expands ZOLL’s position as the leading provider of high technology systems for precise temperature management,” said James Palazzolo, President of ZOLL. “This underscores our commitment to provide a wide variety of clinical temperature therapies based on physician preference and clinical judgment.”

The InnerCool assets also provide ZOLL with a rich patent portfolio and pipeline of future products. InnerCool will be integrated into ZOLL’s Temperature Management business in San Jose, Calif.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X